In a report released today, Joseph France from Cantor Fitzgerald reiterated a Buy rating on Omega Healthcare (NYSE: OHI), with a price target of $34. The company’s shares opened today at $31.25.
France said:
“: We are reiterating our $34 price target and Overweight rating after meetings with the company last week. We believe that the company’s issues with a handful of operators are nearer resolution, and that occupancy will stabilize in 2018 and could improve in 2019. The sale of Orianna’s remaining properties is on track to close by year-end, Signature’s restructuring is complete, Daybreak is current and OHI appears to be making headway transitioning Preferred’s facilities in New Mexico and Arizona.”
According to TipRanks.com, France is a 5-star analyst with an average return of 13.7% and a 60.6% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and US Physical Therapy.
Omega Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $30.50.
See today’s analyst top recommended stocks >>
Omega Healthcare’s market cap is currently $6.21B and has a P/E ratio of 88.93. The company has a Price to Book ratio of 1.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Omega Healthcare Investors, Inc. engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities. Its portfolio consists of long-term leases and mortgage agreements. The company was founded on March 31, 1992 and is headquartered in Hunt Valley, MD.
